Selective ablation of LGR5+ CSCs in LGR5-iCaspase9 knock-in organoids initially leads to tumor regression, but followed by tumor regrowth driven by re-emergence of LGR5+ CSCs from other cells [75]. Here, LGR5 is linked to neoplasm.